Lydia Meder

Bayreuth, BY 95445, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications

Single-cell insights into tumor microenvironment heterogeneity and plasticity: transforming precision therapy in gastrointestinal cancers.

Single-cell insights into tumor microenvironment heterogeneity and plasticity: transforming precision therapy in gastrointestinal cancers.

Journal: Journal of experimental & clinical cancer research : CR
Published: July 31, 2025

Aberrations in the glycosylation of receptor tyrosine kinases: A focus on lung adenocarcinoma.

Aberrations in the glycosylation of receptor tyrosine kinases: A focus on lung adenocarcinoma.

Journal: CytoJournal
Published: January 31, 2025

ERBB2 signaling drives immune cell evasion and resistance against immunotherapy in small cell lung cancer.

ERBB2 signaling drives immune cell evasion and resistance against immunotherapy in small cell lung cancer.

Journal: Nature communications
Published: November 13, 2024

TAT-CRE inhalation enables tumor induction corresponding to adenoviral Cre-recombinase in a lung cancer mouse model.

TAT-CRE inhalation enables tumor induction corresponding to adenoviral Cre-recombinase in a lung cancer mouse model.

Journal: Communications biology
Published: September 12, 2024

Editorial: Tumor and immune cell interactions in the formation of organ-specific metastasis.

Editorial: Tumor and immune cell interactions in the formation of organ-specific metastasis.

Journal: Frontiers in oncology
Published: January 19, 2024

Somatic rearrangements causing oncogenic ectodomain deletions of FGFR1 in squamous cell lung cancer.

Somatic rearrangements causing oncogenic ectodomain deletions of FGFR1 in squamous cell lung cancer.

Journal: The Journal of clinical investigation
Published: March 07, 2023

The role of LIN28B in tumor progression and metastasis in solid tumor entities.

The role of LIN28B in tumor progression and metastasis in solid tumor entities.

Journal: Oncology research
Published: November 30, 2022

Blocking the angiopoietin-2-dependent integrin β-1 signaling axis abrogates small cell lung cancer invasion and metastasis.

Blocking the angiopoietin-2-dependent integrin β-1 signaling axis abrogates small cell lung cancer invasion and metastasis.

Journal: JCI insight
Published: October 18, 2022

Tripartite antigen-agnostic combination immunotherapy cures established poorly immunogenic tumors.

Tripartite antigen-agnostic combination immunotherapy cures established poorly immunogenic tumors.

Journal: Journal for immunotherapy of cancer
Published: September 18, 2022

Trophoblast Cell Surface Antigen 2 (TROP2) as a Predictive Bio-Marker for the Therapeutic Efficacy of Sacituzumab Govitecan in Adenocarcinoma of the Esophagus.

Trophoblast Cell Surface Antigen 2 (TROP2) as a Predictive Bio-Marker for the Therapeutic Efficacy of Sacituzumab Govitecan in Adenocarcinoma of the Esophagus.

Journal: Cancers
Published: August 30, 2022

EGFR Inhibition Strongly Modulates the Tumour Immune Microenvironment in EGFR-Driven Non-Small-Cell Lung Cancer.

EGFR Inhibition Strongly Modulates the Tumour Immune Microenvironment in EGFR-Driven Non-Small-Cell Lung Cancer.

Journal: Cancers
Published: July 21, 2022

SQSTM1/p62 promotes miR-198 loading into extracellular vesicles and its autophagy-related secretion.

SQSTM1/p62 promotes miR-198 loading into extracellular vesicles and its autophagy-related secretion.

Journal: Human cell
Published: May 11, 2022
Showing 1-12 of 33

Last Updated: 09/26/2026